rs587784174
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_022455.5(NSD1):c.6014G>A(p.Arg2005Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_022455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Sotos syndrome Pathogenic:3
The missense c.6014G>A p.Arg2005Gln variant in NSD1 gene has been reported in heterozygous state in individuals affected with Sotos syndrome Douglas J et al. 2003. Functional study found R2005Q reduced the activity of the H3K36 HKMT Qiao et al., 2011. The p.Arg2005Gln variant is novel not in any individuals in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic/ Pathogenic. The amino acid change p.Arg2005Gln in NSD1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 2005 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Beckwith-Wiedemann syndrome Pathogenic:1
This sequence change replaces arginine with glutamine at codon 2005 of the NSD1 protein (p.Arg2005Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with Sotos syndrome (PMID: 12464997), and in another individual referred for genetic testing of Sotos syndrome (PMID: 16247291). ClinVar contains an entry for this variant (Variation ID: 159395). Experimental studies have shown that this missense change has greatly reduced H3K36 histone methyltransferase activities in vitro (PMID: 21196496). The observation of one or more missense substitutions at this codon (p.Arg2005Gly) in affected individuals suggests that this may be a clinically significant residue (PMID: 26690673). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
Segregates with disease in affected individuals from a single family referred for genetic testing at GeneDx; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate a damaging effect through reduction of H3K36 histone lysine methyltransferase activity (Qiao et al., 2011); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12464997, 33942996, 21196496, 27834868, 16247291, 16010675) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at